Lifeward Ltd.
LFWD Nasdaq Orthopedic, Prosthetic & Surgical Appliances & Supplies Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$6.06
4.2%What Lifeward Ltd. does
No business description yet.
- Legal name
- Lifeward Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 18, 2026
- Accession ยท CIK
- 0001178913-26-001208
0001607962
Revenue and margins
Lifeward Ltd. had $22.0M of revenue in fiscal 2025, down 14.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$16.8M in fiscal 2025, โ76.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lifeward Ltd. returned โ to shareholders in fiscal 2025. The diluted share count rose 60.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Lifeward Ltd. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $88.3M | $67.9M | $28.1M | $6.7M | $2.2M |
| Current ratio | 22.9x | 15.2x | 3.3x | 2.1x | 1.3x |
| Quick ratio | 22.2x | 14.6x | 2.8x | 1.4x | 0.8x |
| Total assets | $94.8M | $74.2M | $63.2M | $30.5M | $22.9M |
| Total liabilities | $5.4M | $6.1M | $16.7M | $11.6M | $14.5M |
| Shareholders' equity | $89.4M | $68.2M | $46.5M | $18.8M | $8.4M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 4 / 9 | 5 / 9 | 4 / 9 | 3 / 8 | 3 / 8 | 3 / 8 | 3 / 8 | 2 / 8 | 4 / 8 |
| Accruals ratio | โ18.1% | โ8.3% | โ36.5% | โ3.7% | โ1.5% | โ2.1% | โ2.0% | โ2.1% | โ15.4% | โ11.6% |
| Altman Z'' | โ13.50 | โ21.75 | โ38.35 | โ22.64 | โ15.51 | 16.03 | 6.66 | โ8.91 | โ30.70 | โ44.62 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.9M | $7.8M | $6.5M | $4.9M | $4.4M | $6.0M | $5.5M | $13.9M | $25.7M | $22.0M |
| Net interest income | โ | โ | โ | โ | โ | $0.0M | $0.0M | $1.4M | $0.6M | โ$0.3M |
| Gross profit | $0.7M | $3.1M | $2.8M | $2.7M | $2.2M | $2.9M | $1.9M | $4.5M | $8.2M | $8.4M |
| Research and development | $9.0M | $6.0M | $7.3M | $5.3M | $3.5M | $2.9M | $4.0M | $4.1M | $4.6M | $3.2M |
| Operating income | โ$30.4M | โ$22.0M | โ$19.2M | โ$14.0M | โ$12.0M | โ$12.7M | โ$19.1M | โ$23.6M | โ$29.3M | โ$19.7M |
| Interest expense | $2.0M | $2.5M | โ | $1.5M | $0.9M | $0.0M | โ | โ | โ | โ |
| Pretax income | โ$32.5M | โ$24.6M | โ$21.7M | โ$15.5M | โ$12.9M | โ$12.6M | โ$19.1M | โ$22.1M | โ$28.9M | โ$20.0M |
| Income tax | $0.0M | $0.1M | โ$0.0M | $0.0M | $0.1M | $0.1M | $0.5M | โ$0.0M | $0.0M | โ$0.1M |
| Net income | โ$32.5M | โ$24.7M | โ$21.7M | โ$15.6M | โ$13.0M | โ$12.7M | โ$19.6M | โ$22.1M | โ$28.9M | โ$19.9M |
| Net income to common | โ$32.5M | โ$24.7M | โ$21.7M | โ$15.6M | โ$13.0M | โ$12.7M | โ$19.6M | โ | โ | โ |
| Diluted EPS | โ$2.47 | โ$30.57 | โ$14.72 | โ$2.70 | โ$0.82 | โ$0.27 | โ$2.20 | โ$31.13 | โ$39.96 | โ$17.16 |
| Diluted shares | 0.01B | 0.00B | 0.00B | 0.01B | 0.02B | 0.05B | 0.01B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | โ$26.7M | โ$22.5M | โ$14.8M | โ$14.8M | โ$12.6M | โ$11.5M | โ$17.9M | โ$20.7M | โ$21.7M | โ$16.8M |
| Capital expenditure | $0.5M | $0.0M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M |
| Free cash flow | โ$27.2M | โ$22.5M | โ$14.8M | โ$14.8M | โ$12.7M | โ$11.5M | โ$17.9M | โ$20.7M | โ$21.7M | โ$16.8M |
| Depreciation and amortization | $0.7M | $0.6M | $0.5M | $0.3M | $0.3M | $0.3M | $0.2M | $0.2M | $0.5M | $0.3M |
| Stock-based compensation | $3.4M | $3.7M | $2.8M | $1.1M | $0.7M | $0.8M | $1.0M | $1.3M | $1.3M | $0.7M |
| Acquisitions | โ | โ | โ | โ | โ | $0.0M | $0.0M | $18.1M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $23.7M | $14.6M | $9.5M | $16.3M | $20.4M | $88.3M | $67.9M | $28.1M | $6.7M | $2.2M |
| Total debt | $18.0M | $15.4M | $8.7M | $7.0M | โ | โ | โ | โ | โ | โ |
| Current assets | $29.3M | $20.9M | $13.2M | $21.1M | $25.2M | $92.5M | $72.5M | $39.2M | $21.3M | $15.8M |
| Current liabilities | $12.4M | $9.7M | $5.4M | $10.2M | $4.7M | $4.0M | $4.8M | $11.8M | $10.2M | $12.0M |
| Inventory | $3.3M | $3.6M | $2.2M | $3.1M | $3.5M | $3.0M | $2.9M | $5.7M | $6.7M | $5.7M |
| Property and equipment, net | $1.3M | $0.8M | $0.6M | $0.5M | $0.4M | $0.3M | $0.2M | $1.3M | $0.9M | $0.6M |
| Goodwill | โ | โ | โ | โ | โ | โ | $0.0M | $7.5M | $7.5M | $4.8M |
| Intangible assets | โ | โ | โ | โ | โ | โ | โ | $12.5M | $0.0M | โ |
| Total assets | $31.8M | $22.9M | $15.0M | $24.4M | $28.1M | $94.8M | $74.2M | $63.2M | $30.5M | $22.9M |
| Total liabilities | $23.5M | $19.2M | $13.0M | $13.6M | $6.3M | $5.4M | $6.1M | $16.7M | $11.6M | $14.5M |
| Shareholders' equity | $8.3M | $3.7M | $1.9M | $10.8M | $21.8M | $89.4M | $68.2M | $46.5M | $18.8M | $8.4M |
| Margins | ||||||||||
| Gross margin | 12.5% | 40.0% | 43.2% | 55.9% | 49.8% | 48.7% | 34.6% | 32.1% | 32.0% | 38.3% |
| Operating margin | โ518.7% | โ283.7% | โ293.6% | โ288.3% | โ273.3% | โ212.1% | โ346.6% | โ170.4% | โ114.4% | โ89.3% |
| EBITDA margin | โ506.8% | โ275.4% | โ286.5% | โ281.7% | โ266.8% | โ207.7% | โ343.0% | โ168.7% | โ112.4% | โ87.8% |
| Net margin | โ553.8% | โ318.8% | โ331.2% | โ319.1% | โ295.4% | โ213.5% | โ355.1% | โ159.8% | โ112.8% | โ90.4% |
| FCF margin | โ463.4% | โ290.0% | โ225.9% | โ304.5% | โ288.2% | โ193.0% | โ325.1% | โ149.8% | โ84.6% | โ76.4% |
| Net interest share of revenue | โ | โ | โ | โ | โ | 0.0% | 0.0% | 9.8% | 2.5% | โ1.4% |
| Returns | ||||||||||
| Return on capital | โ926.7% | โ386.8% | โ1,397.7% | โ743.8% | โ | โ | โ | โ | โ | โ |
| Return on capital employed | โ157.2% | โ167.4% | โ200.6% | โ98.9% | โ51.3% | โ14.0% | โ27.5% | โ45.9% | โ144.8% | โ181.1% |
| Return on equity | โ393.5% | โ413.1% | โ767.0% | โ244.4% | โ79.7% | โ22.9% | โ24.8% | โ38.6% | โ88.6% | โ146.1% |
| Return on assets | โ102.3% | โ90.5% | โ114.6% | โ79.1% | โ49.5% | โ20.7% | โ23.2% | โ32.2% | โ61.8% | โ74.6% |
| Return on tangible equity | โ393.5% | โ666.8% | โ1,114.4% | โ144.3% | โ59.6% | โ14.2% | โ28.7% | โ83.7% | โ255.9% | โ545.1% |
| Growth | ||||||||||
| Revenue growth | โ | 32.1% | โ15.6% | โ25.5% | โ9.9% | 35.8% | โ7.6% | 151.4% | 85.2% | โ14.1% |
| Share count change | โ | โ93.9% | 82.1% | 291.4% | 173.5% | 204.1% | โ81.4% | โ92.0% | 1.9% | 60.2% |
| Financial health | ||||||||||
| Debt / equity | 2.2x | 4.1x | 4.5x | 0.6x | โ | โ | โ | โ | โ | โ |
| Interest coverage | โ15.4x | โ9.0x | โ | โ9.4x | โ13.2x | โ | โ | โ | โ | โ |
| Current ratio | 2.4x | 2.2x | 2.5x | 2.1x | 5.4x | 22.9x | 15.2x | 3.3x | 2.1x | 1.3x |
| Quick ratio | 2.1x | 1.8x | 2.0x | 1.8x | 4.7x | 22.2x | 14.6x | 2.8x | 1.4x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.7% | 0.3% | 0.2% | 0.5% | 1.7% | 0.8% | 0.5% | 0.6% | 0.0% | 0.1% |
| Stock comp / revenue | 57.9% | 47.1% | 42.3% | 22.7% | 17.0% | 14.0% | 18.0% | 9.6% | 5.0% | 3.4% |
| Quality scores | ||||||||||
| Piotroski F-score | โ | 4.0 | 5.0 | 4.0 | 3.0 | 3.0 | 3.0 | 3.0 | 2.0 | 4.0 |
| Altman Z'' | โ13.5 | โ21.8 | โ38.3 | โ22.6 | โ15.5 | 16.0 | 6.7 | โ8.9 | โ30.7 | โ44.6 |
| Accruals ratio | โ18.1% | โ8.3% | โ36.5% | โ3.7% | โ1.5% | โ2.1% | โ2.0% | โ2.1% | โ15.4% | โ11.6% |
Source: SEC EDGAR XBRL filings (CIK 0001607962). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
